Pulmonary vascular disease & thromboembolism

Noninvasive Estimation of Pulmonary Vascular Resistance Using Right Ventricular Outflow Doppler Analysis

JACC AdvPublished prospective study

Authors' conclusion

This novel echocardiographic method offers feasible, rapid, reliable PVR estimation with strong correlation to invasive measurements. Although not a substitute for RHC, this promising preliminary finding from a selective cohort may aid in identifying candidates for invasive testing and guide pulmonary hypertension management. Larger, multicenter validation is warranted.

Study context

Population
Patients undergoing right heart catheterization with interpretable right ventricular outflow tract Dopplersof 95 patients undergoing right heart catheterization (RHC), 35 with isolated postcapillary pulmonary hypertension (pulmonary vascular resistance (PVR) <2.0 WU) and no discernible Doppler notches excluded
Participants
54 patients
Exposure
The model was validated against invasive PVR (iPVR) and compared with 5 existing methods.
  • Derivationn = 30
  • Validationn = 24
Outcome
Predictor of iPVR (stepwise linear regression)
Methodological detailsdevelopment and validation of a novel echocardiographic method
  • Development and validation of a novel echocardiographic method

Main finding

As reported in the abstract

Model R2 after adjusting for heart rate

0.93

Equation

non-iPVR = 7.1∗(ejection time/NT) - 9.36

Observational data: associations, not effects.

Further findings

Validation against 5 established methods

Superior performance across PVR range
2.3 to 14.2 WU
Pearson correlation
r: 0.76; P < 0.0001; 95% CI: 0.52-0.89
Bland-Altman analysis confirmed superior agreement

Original publication

Noninvasive Estimation of Pulmonary Vascular Resistance Using Right Ventricular Outflow Doppler Analysis. JACC Adv. Published 18 August 2025. doi:10.1016/j.jacadv.2025.102079

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.